Brightstar Associates LLC 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Mar 1, 2023
Insider Transaction Report
Form 4
Brightstar Associates LLC
10% Owner
Transactions
- Exercise of In-Money
Warrants (right to buy)
2023-02-28−2,427,693→ 962,137 totalExercise: $0.01From: 2022-04-28→ Common Stock (2,427,693 underlying) - Exercise of In-Money
Common Stock
2023-02-28$0.01/sh+2,427,693$24,277→ 22,145,707 total
Footnotes (1)
- [F1]The warrants have no expiration date.